Approach to First-Time Seizure in Patients with Cerebral Palsy

Initial Management and Observation

The American College of Emergency Physicians recommends that patients with first unprovoked seizures who return to clinical baseline need not be admitted, but cerebral palsy represents an underlying brain disorder that substantially modifies this recommendation, suggesting admission for observation rather than immediate discharge 1.

Patients with cerebral palsy have a significantly elevated seizure recurrence risk, with a baseline risk of seizure recurrence after a first unprovoked seizure of approximately one-third to one-half within 5 years 3.
The American Academy of Neurology recommends obtaining brain MRI to characterize the extent of structural abnormality and identify any additional epileptogenic lesions, and performing EEG to assess for epileptiform activity, which increases recurrence risk even with normal imaging 3.
Checking glucose level is recommended, as hyperglycemia is associated with early seizure recurrence 2.

The World Health Organization recommends against routine treatment after first unprovoked seizure, but this guideline does not apply to patients with underlying brain disorders like cerebral palsy, and initiation of antiepileptic drug therapy is recommended immediately 3.
Levetiracetam is recommended as first-line monotherapy, with an initial dose of 500 mg twice daily, and valproate should be avoided if the patient has any possibility of being female or if there are concerns about teratogenicity 3.

The American College of Emergency Physicians recommends admitting patients for observation for at least 6 hours, preferably 24 hours, given the cerebral palsy, and arranging urgent neurology follow-up within 1-2 weeks 2, 4.